Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at straitstimes.com. Read more at straitstimes.com.

The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten ...

In her nine months as scientific adviser to U.S. Food and Drug Administration Commissioner Marty Makary, Tracy Beth Høeg’s ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

IL, and U.S. Rep. Rosa DeLauro, D-CT, have reintroduced the Federal Food Administration Act. The act is designed to ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the ...

Today, the U.S. Food and Drug Administration conditionally approved Exzolt Cattle-CA1 (fluralaner) topical solution for the ...

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...